Nobivac NXT FeLV (Canada)

Company: Merck Animal Health

FELINE LEUKEMIA VACCINE, RNA PARTICLE

FOR ANIMAL USE ONLY

In the absence of a veterinarian-client-patient relationship, federal regulations prohibit the relabeling, repackaging, resale or redistribution of the individual contents of this package.

Adjuvant, preservative, antibiotic and thimerosal free

PRODUCT DESCRIPTION: Nobivac^® NXT FeLV is a non-adjuvanted, freeze-dried injectable feline leukemia virus vaccine, utilizing RNA particle technology. The vaccine stimulates expression of the desired antigen to induce a protective immune response against feline leukemia virus, including protection against persistent viremia in cats.

Nobivac NXT FeLV Indications

This product has been shown to be effective for the vaccination of healthy cats 8 weeks of age or older against feline leukemia virus. Duration of immunity is at least 2 years. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

This product has been shown to be effective against persistent viremia in cats exposed to virulent feline leukemia virus.

Dosage and Administration

Transfer contents of the sterile diluent vial to the Nobivac^® NXT FeLV vial aseptically and mix gently until dissolved. For primary immunization, administer 1 dose (0.5 mL) subcutaneously as early as 8 weeks of age, followed by a second dose administered 3 to 4 weeks later. Contact your veterinarian or manufacturer for more information on revaccination frequency.

Precautions

● Store at 2°-8°C (35°-46°F).

● Do not freeze.

● Use new, non-chemically sterilized needles and syringes.

● Do not mix with other products, except as specified on the label.

● In case of human exposure, contact a physician.

Warnings

● Vaccinate only healthy, non-parasitized cats.

● This product has not been tested in pregnant animals.

● Do not administer to horses or other equine species.

● The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

Intervet Inc. d/b/a Merck Animal Health

Omaha, NE 68103 USA

VLN 165A/PCN 1555.R8

1 800 224-5318 (USA)

1 866 683-7838 (Canada)

For patent information:

http://www.merck.com/product/patent/home.html

CPN: 1208343.0